EUVIMEDEUVIMED entdecken
Crossref

Esterase-Responsive Self-Assembled Torkinib Prodrug Nanoparticles Alleviate Atherosclerosis via Macrophage mTOR Inhibition

Lujie Zhu, Tongyu Li, Yuyun Yan, Jinhui Shang, Yantao Du, Tianhui Zhou, Fangkun Yang, Hanbin Cui, Ning Huangfu, Jiaxi Shen iD

ACS Applied Materials & Interfaces · 05.08.2026 · 18 (30) · 40461-40475

DOI: 10.1021/acsami.6c10454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 20.07.2026. Verfasst von Lujie Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang315010, China. Hauptthemen laut MEDLINE: Nanoparticles, Atherosclerosis, Prodrugs, TOR Serine-Threonine Kinases. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis remains a major threat to human health due to unresolved plaque inflammation and macrophage dysfunction. Although stimuli-responsive nanocarriers (e.g., pH- or ROS-sensitive systems) have been exploited for targeted drug delivery, they suffer from modest signal gradients, spatial heterogeneity, or unpredictable release in atherosclerotic lesions. Herein, we report an esterase-responsive, carrier-free self-assembling prodrug nano-platform (LPNP) that exploits the unique pathological microenvironment of atherosclerotic plaques for targeted mTOR inhibition in lesional macrophages. The dual mTORC1/2 inhibitor Torkinib (PP242) was covalently conjugated to linoleic acid (LA) via a labile ester bond, enabling spontaneous nanoparticle formation without exogenous carriers. This ester bond remains stable during systemic circulation but is efficiently cleaved by intracellular esterases—highly active in macrophage-derived foam cells—enabling lesion-specific drug release. In vitro, LPNPs were readily internalized by macrophages, where they suppressed S6K phosphorylation, activated autophagy, reduced ROS levels, and upregulated ABCA1/ABCG1-mediated cholesterol efflux, thereby reducing lipid droplet accumulation and promoting M1-to-M2 repolarization. In an ApoE–/– mouse model, LPNP administration significantly reduced plaque burden, increased collagen deposition, and enhanced plaque stability without altering systemic lipid profiles or causing overt toxicity. Collectively, this esterase-responsive prodrug strategy couples carrier-free self-assembly with macrophage-associated intracellular activation, providing a promising approach to enhance lesional macrophage mTOR inhibition for atherosclerosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesAtherosclerosisProdrugsTOR Serine-Threonine KinasesMacrophagesEsterasesAnimalsMiceRAW 264.7 CellsHumans

Stichwörter der Autor:innen

Torkinibatherosclerosisesterase-responsivemTORmacrophage repolarizationself-assembled nanoparticles

Substanzen

ProdrugsTOR Serine-Threonine KinasesEsterases

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang315010, China.
  • Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang315010, China.
  • Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang315010, China.
  • Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina27705, United States.

ORCID-Profile: Jiaxi Shen

Förderung

  • Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Zhu, L., Li, T., Yan, Y., Shang, J., Du, Y., Zhou, T., Yang, F., Cui, H., Huangfu, N., & Shen, J. (2026). Esterase-Responsive Self-Assembled Torkinib Prodrug Nanoparticles Alleviate Atherosclerosis via Macrophage mTOR Inhibition. ACS Applied Materials & Interfaces, 18(30), 40461-40475. https://doi.org/10.1021/acsami.6c10454

Vancouver

Zhu L, Li T, Yan Y, Shang J, Du Y, Zhou T, et al. Esterase-Responsive Self-Assembled Torkinib Prodrug Nanoparticles Alleviate Atherosclerosis via Macrophage mTOR Inhibition. ACS Applied Materials & Interfaces. 2026;18(30):40461-40475. doi:10.1021/acsami.6c10454

BibTeX
@article{Zhu2026,
  author = {Zhu, Lujie and Li, Tongyu and Yan, Yuyun and Shang, Jinhui and Du, Yantao and Zhou, Tianhui and Yang, Fangkun and Cui, Hanbin and Huangfu, Ning and Shen, Jiaxi},
  title = {Esterase-Responsive Self-Assembled Torkinib Prodrug Nanoparticles Alleviate Atherosclerosis via Macrophage mTOR Inhibition},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {30},
  pages = {40461--40475},
  doi = {10.1021/acsami.6c10454}
}
Kostenlos starten →